<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clopidogrel improves outcome in an acute coronary syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clopidogrel improves outcome in an acute coronary syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clopidogrel improves outcome in an acute coronary syndrome</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAgoAAAFECAMAAABxpebmAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAbFBMVEX///9Kbv//KCimuP//CAjv8PYzMzOAgIAAAAAHOP//fHz/nJympqZ/mP8RERHG0v//WVkoU///yMiJh4jR0dF3d3f/8PBWVFRmhf+9vb3/r6/g5v//QEBCQkIiIiJoYmj/4OCOpf+tFypGPslSN/lGAAAQHUlEQVR42uydiXaqOhSGmcs8gxRQ8f1f8iRgte1RCxIgCf+/6njqXRfzdQ/Jzo6iQBAEQRAEQRAEQRAEQRAEQRAEQRAEQRAEQRAEQRAESabPj0Gf+CqAQq/jB74KqNcHUICAAgQUNpVhPHq3NmKgsBelBlGbAgUoNTQy4BpQgCgKJeGA/LjEPmi1krbksfQ0g2BAINGMtuz/yQUKkg295w5K7yh4ZNAHq+AaraIZ6fB2bHjUKriGS36U1qiBgizqvFgztPg3CkRxSVGoqTnQKARKbwaIIbiiEBMM3I3MAlBgbg1czYi99KGDuGYQhlHTVzercI0VWlgFSVSmxCfEhuamT2OFKwrEEhCr8S1WoFaB2gwFsYLg7sCNWzqqbRu7XifsdQAFBu7A9dK0FP5SgMIMj+BRd1DLcjlA4e1csTVaL5XoioDCO6r7LKGU66KAwmR5z7MEoLCn+MDVNIGzBKDALG906dqipAIKEyLF2IhTeS8PKIwGoTXcTuYLBAojcwZNc0u5LxEojDMJhif9NQKFUXmDJj8JQGGUtFgBChBRrClAASLytBIo7DtU/CpONFIFKOyXgu/FibUCFHZMgZfu7sqBwh2C1JWdgk/7QO4Ptm1nipJbdv8SKPxgwG0JBK0ruS24jv0hJ88+lVNoZnYBFK6q44EBN92FQ8i/zIBl+7ltKfQGFIY00dgJA79QONonxSfPBxTQdYVOHe0sOBxQyE92mCt3qwAUSm0fU0e/Ucht28rJC8QKt2BxFwsLv8NG285zek+9AzIIoi6t3R0sO2Ne4WWg6F73tO1lDhEoPAFB09w67TDsO0chJSDAKQAFj7iFFiAAhbTVdri+BBT+zxdiwy0x1EChdI0YgSJQUDpPa+Eado9CWccaYkWgQDvjSLn3HShMMge0BUJcI1TcOQqUg5jjFgiO8/h91dGff0h1IqDwDgd8moNGdRyn+R+FZBhmoLATDhTFTMhY6yqswvLyWg45aKLgawwvTvXlIExiHxKdmIPEIeNPh7kiBoM8Dcj9ZTAfjhk4qhNcfxUoTABB0zjjwNQrMoxq9TWGARnkKwrEABAbQX6ipn8VXRyVvnlxAvqgkt/sUXCcgLxsnAQojPQLae1yt+YYVY4aRM23d4K7VSDjTEyCToME8pQMM8WkZ4AaBoJANKBwob/dWwig8KctoLXrhtbGfIHQBEkSNM9jhbtViIa/+Ks5uFkF/YaCOtiS6Sjkvumbu0FhKEThyy1EkU6MehW9zCBusQJ5iPphpm/cYoWoDyIGFMw+bpiOQmbbvnXeBwo8FaI0URQElUpHLVHVQB/515g8H19qLWbpZJ38wtoBCjUnhSgkMlTp37aqVkEQRc20Tz9DQR+sxayYldgE/yw/CmVs8FGIojuVHkVcfkens1WEcjsImi7QE5j4IEHn9nvybZtugZIThdJzr+nClmXrenBTxTEJivJZZNNIEAaFtD+FY/N0IXKqOwpck5APN9lQoEdtcdFU10wCQWyoVSiKfBkE7bLNSdqoqmKA8GmFJ8sK5UKhczWNmy7bQWKKgYLf75ANfYlQqIlB4GRvYxTplRMpgsg8Z6Y5kVuOUehcY/PVRjqPHPTTSP00ojhJdxYSsyCHg+ho+cF280jR5Q5AwOs00iudTrYVHkZGFhx3Xem8LQ9s0wkDSSUkAHcHYWe2eRYdhXTbg/v0JLkIzMANBd8qDkI7iDrWtC0DRQKCrsgg61DYtrBrEOXmBzhKA8IQOWaCZhB1a2x9gKN5rT6UQefz5I9wggJdd+62/p8QZS5xjCbGCfygUG+67mzq15VGUx4UsrAoikw4FIhJqDfkQHXUYalRojhhaNEoXAaxoUmILoQDXSJjcJ8r8Ik+xUKhazcyCRQDSTl4T1uj4G7SJol6BUeVYCpJHhRSbYPe6310AAy4QqEkJmETDuAV+EKh9Iy2AweLyB8kRthIy1ZrcLDQpdqDBEgmN6hS25dfKIrTgdy4X47aoCilUZN9xQem7RMgjlyjULrr98QwAyfYW6AYWr5v8ewgunhtg2BGepCojbI3ZTRW4LfimW5oWC9CaPRqqE6sdGWH+iyKaQnEiijQxhireYYoSBw10KPdTiBwXK+wZmMMvUqSfZqCu7itV1gPhOaiOkmAWWVO6xXWAsEk5sBR9UaB+KxXWAmEHgOYg1vUyN3Ec7kKCFFAvMLeo4PfDoIvq0AXGpYGgS4tEAyw1vhTUzbKLY4CNQiLLzTolaNeEBz8/wcyZaPcwiissR0+qpwEHDxBgZONct0KCw3NJXncNBXqMwguNsrRbdALLzTQElWEiX9Fjs+mFej6BPEdudU/LIcCPei1XJSCKkGc+DcHvqL4j1nwCQBnO1NOoZnZxWIoLHnQaxQFPQWoUB3jIMhYP+nQltthcQjznOSa+fd8kykKix302i8yJiooGI9CaBfPmvUdqIMwqXEYUFig1cZiB71WThABgmkoFIX9pFlfRgzG0T7frQJ7FDxjmemkJkmQMU5HgQz5MxTO/W25WIE5CdFl2NV6PWgHYhQ2kpixzzMXyyDYkjBsaJRvg/OK2qxvI0MSsKGRhVXYajmqZEcCPYoNGMzWRstR7BYgHx7FBr1hWTdZjqqZzTPrKlYVmKGw/nIU7afFZHrRJAYBs8nsksnVl6NYNc9pSIQAg8A4clyzbyOrflokVIRnYOwhslUrnhmZhIiECAgVGeu4ZsUzI5Ogk5wBIQL7sNFar+KZiUnoY0UM3BJhYzH5I2+iwMQkIFZcSkVxPK0UK7AwCYgVF3QPqzXg8eabBMSKS2q1tlyxMXd2EbEih5qOQhlrM52DqTqIFSVAodTmhgm6o8IiSIBCasQwCSIo903fXBKFemZdggmTsI4y2/atJZej3HmpA93kCJOwik7WyV/wpHoSMM5IHVCWsurMgm/558VQSGcEjCbKUla2CmerCJdyEN77HftpvSLKUlaVb9t2mC+DQvduwAjHsIk+i2waCeNR0N6yCf3udziGDXLJ5eYVXG36f1vHOV2bybKmGoWxKHhGN9kgSHHku6iim+EOS7T7nr7jJVIlOuBZSA/hW0ssUk8moakcrDxuGzWeTz83x7JBYSoJZuVUAGHjWME+ndkfAjCRBDNAUcr2yvzJH/kbhYkkXFCvuL2KnG6DGFvbOLbryjQS9CQBCJuLrkBMqG0ci8KkPdIVahG4kG8u0PndmzC1hKZJHGUQ+XBjiMIEo6CjaRJHGUShKGzrFUYbhSZAVQpHNsEKT5YVskShHFm1hO0tnMUK/Y6YkOXEcxyPSxscrEJzlkOcM7Yd2mpjRNkSPe8Z3z1vYtyhLR3hHvZ43rMIYtuhrRyRPeh7PO9ZBAfBtkOb9megAN/ALwosO7TFf+WR8A08zysw7NDm/bFJNrrAN3AeOTLq0Fa/2jhPT3pNVPgGufQEhe5V8hA5OPCXbxWDmDTgeVXqbiYBvmzOg0Z2DXhelrqrKr5szsWuAU/9qtQ9SJA2CBAzsnEQrxahzIuDOEGEZJKNg3DbpwEjGiQIIlrFFM62Cukz96DjFGixLMNxLgpPsodIxXkNQsUK59kO4nH20GDjm3ixwszSle7RNCM2vokYK8ztr9D+7x6w30nAmYWjZc3s0PagcOniYN1JOIXzk8n/ylX0BBvfREThPLe2sfttFHREi2JmEMe5E89u/JsEzCgJqfNsB/GrRydIEFSmbc1cg0g1kCCHjufJH/mJQuyCBDl0COclk+WP1QeQILBer0we6T/l1s9uTT9Q8FqQIE208CKZLEKKwik0M7t4gkLsgQRZkskXpSt+6BMU8uvtMQrf/ANIkNZBfNo+RcAn3mFA4UEDnm/5g5lgZklovShdOQwlsHer8AAF954/BChllcAyPC1dyf+KFe7zSw0KGMWPFV6UruR/ZBCdcXtaoauSDLHC26UrXvz1LHKwKi1BrPB+6co9lVSx/WmH+obCLZXUselFcPmWf717C4VbKmliSkF0HUJ6/3YDnlsqiT2R4geN1v3+DRS+UkndgXsQHoWQjKH5bgvPr1QS7kGGWQX7VBQn+83Sla9UEu5BBvX1bNP2yd1RuKaScA+SzCsUxdRzYm4oDKEC3APmFUoD7gEo9KpbuAeg8G1WAX00gILS0p47UYIvBCj0G+SwDAUUhgWIBpECUBgmmFCwAhSGqNFEwQpQIFFjitJWoNA/0LlGHCEMFGgCQWuX8G0AhT6BwPkOQIGi0CoKgkagMCQQmGkECvQ+9jCpABQ+rgkE8gegoPTFCo2D7wIo9MUKOuaXgMIQNaropwAUlL5YAankfvW91YZRIpUEChSFVFMCpJJwEB99sQKKGiGKQuyaqF+CKAptilVJqEfB6CrUt0IEhc7ArDPUo5C2/9o7G960YSCAoomEU+V5Ve3ISkWSjv7//7g75wMqtmmT4io070lUAoKh9uPi8xlg1RmyCk/PP1l1hqzC03emCmAqnF/ZywajCi/8fCBkFY5v1KJgVOFAAgGmwtuRXBKyCi/nH+SSYCq8ntnMBlkFlhVgUYFiFEwqsKwAkwosK8CsAt0AWYVAAgFZheeB3c6QVTi/k0BAVuH4TgIBpsJwJIGArEL6RgIBRnO5kEBAjgoXEgiYVCCBgFEFEoi9EmuR9EEFEoid0vsqSHO9Ho4kEDsNClLny4IjgdgpTs8OowrTt65chvcTlKTdfFRYVHBFOqDrCvVsqYaLtXt6lLnCqdArLdXuw73g02ZVuMsgUGGvKjx8D6ACKqACKqACKqDCp9K2j9Xuw73gtj0AAAAAAAB8MapOpIvrt+ukTLvaci231bS1iNYRq/8QQpvLPUk7I2xehSTuw0aWtRic2tCVMOFDLW09amnXb3qq/KVozW9dBS9VvhQZtAJv3kMnvXi3fnQUr53hV481s121uI2bMPZACRWiiI9l3I3rD9nh0EssqIIKfNhxVIhF/n0bslrWl8x5DTd9GRViX+ZtsfpcoS0xV+icTplKqNBIiL7MW2xYP4hnFTRA1ts3oVgGMRTLIFKZhoOO1+om6LRRJEb7W2i2CwAAAAAAAAB35AXx393ejXfEfsnTvT+EB6j7wd/wNpzpbq3TPtH5JxXmQe+uS8+o8CVUyCtx/6NCM60N19eyCSp8CRV8Sl5VsNXv3un4JpGQl2lVhc5KOE518dOZQQ8JMm5bsb0gzj4H3MVZBTsyabRw4w3NZE7QZ4mNlNnuAuupoEMbVIUkrup9VUvbil+iQpBULRW96ZA0RQUrpupVq6SNKtj+G31gkEGdaHtpbfm/WlQIj7B3ZNcqVH1vY2gDW4urJVY3KtimomGu40yH3KhgD6x0uEcV7EFO6sr3Q9cPc030RoW0+b0jO1dh/BaYJSpMKgyLCnpm8HmG+I9RQc8Q3g1+njs0esuoQtVLpMe3r4JNBGqbK2QVVAmZVLB5gw/zXEEPuVXhfq4w5O210S7jM2jO2WUV9E6CAoznCQBUAAAAAAAAAAAAAAAAAAAAAAAAAAAA+Gx+Aceq9cscGBP+AAAAAElFTkSuQmCC"/></div><div class="graphic_lgnd">In the CURE trial, 12,562 patients with an acute coronary syndrome were randomly assigned to clopidogrel or placebo in combination with aspirin. After a one-year follow-up, the incidence of the first primary outcome (cardiovascular death, nonfatal myocardial infarction, or stroke) was significantly lower with clopidogrel (9.3 versus 11.4 percent for placebo). This benefit was largely due to fewer nonfatal infarctions.</div><div class="graphic_reference">Data from Yusuf S, Zhao F, Mehta HR, et al. N Engl J Med 2001; 345:494</div><div id="graphicVersion">Graphic 56356 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
